Glenmark Pharmaceuticals Ltd. sees decline in stock price, underperforms sector and Sensex

Glenmark Pharmaceuticals ., a leading player in the pharmaceuticals and drugs industry, has recently seen a decline in its stock price. On November 12, 2024, the company's stock lost -4.06% of its value, underperforming the sector by -2.93%. This has led to a 'Hold' call for the stock by MarketsMOJO.

The stock has been on a downward trend for the past two days, with a consecutive fall of -4.74% in this period. On the same day, the stock also touched an intraday low of Rs 1550.15, a decrease of -5.19%. However, it is worth noting that the stock's moving averages are still higher than the 100-day and 200-day averages, but lower than the 5-day, 20-day, and 50-day averages.

In comparison to the overall performance of the Sensex, Glenmark Pharmaceuticals Ltd. has underperformed with a -3.64% return, while the Sensex has only seen a -0.89% decline. Similarly, in the past month, the company's stock has seen a -12.24% decrease, while the Sensex has only seen a -3.19% decline.

While the stock may have seen a recent decline, it is important to note that this is a fact-based article and does not mention any future potential or recommendations from experts or investors. Glenmark Pharmaceuticals Ltd. remains a largecap company in the pharmaceuticals and drugs industry and its performance should be closely monitored by investors.